Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,676 | -5,738 | -4,015 | -2,537 | -7,948 |
| Depreciation Amortization | 220 | 165 | 110 | 55 | 202 |
| Accounts receivable | -92 | 53 | -113 | 95 | -219 |
| Other Working Capital | -369 | -1,035 | -616 | 94 | -566 |
| Other Operating Activity | 932 | 599 | 611 | 120 | 1,247 |
| Operating Cash Flow | $-6,986 | $-5,957 | $-4,022 | $-2,174 | $-7,283 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -9 | -9 | N/A | -160 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -500 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -2 |
| Investing Cash Flow | $-9 | $-9 | $-9 | $N/A | $-662 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,216 | 5,216 | 5,216 | N/A | 10,681 |
| Other Financing Activity | -562 | -562 | -562 | 0 | 0 |
| Financing Cash Flow | $4,654 | $4,654 | $4,654 | $N/A | $10,681 |
| Beginning Cash Position | 8,913 | 8,913 | 8,913 | 8,913 | 6,177 |
| End Cash Position | 6,572 | 7,601 | 9,535 | 6,738 | 8,913 |
| Net Cash Flow | $-2,341 | $-1,312 | $622 | $-2,174 | $2,736 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,986 | -5,957 | -4,022 | -2,174 | -7,283 |
| Capital Expenditure | -9 | -9 | -9 | N/A | -160 |
| Free Cash Flow | -6,995 | -5,966 | -4,032 | -2,174 | -7,443 |